Thermo Fisher Scientific Inc. snapped up North Carolina-based Patheon N.V. in a deal valued at $7.2 billion.
Biotech innovator Henri Termeer, the longtime chief executive officer of Genzyme and a pioneer in orphan drug development, passed away at the age of 71 years.
The GAVI global vaccine alliance said some 300,000 emergency doses of an Ebola vaccine developed by Merck could be available in case of a large-scale outbreak, after the World Health Organization confirmed a fatal case in Congo.
Patients with episodic and chronic migraine reported fewer debilitating headaches after using Eli Lilly’s experimental drug compared to those on placebo.
A trial of AstraZeneca’s key immunotherapy drug durvalumab showed it reduced the risk of death from advanced lung cancer.
Shares of Capricor Therapeutics plunged nearly 60 percent in premarket trading after the company announced it was laying off an unknown number of employees following the failure of a mid-stage cardiovascular drug trial.
Neil Woodford, of UK’s Woodford Investment Management, unloaded his company’s shares of London-based GlaxoSmithKline. His concerns include a weak pipeline and few strategic options.
Five major chocolate and candy companies announced a joint commitment to reduce calories in many sweets sold on the U.S. market, a rare example of cooperation in a competitive industry and testament to a rising consumer distaste for sugar.
The world needs greater transparency on the pricing of medicines – and an overhaul of some approaches – in order to increase access to life-saving drugs, global health experts said.
John Mangano was named senior VP, Strategy and Analytics, at Digitas Health – the Agency of Now.